↓ Skip to main content

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

Overview of attention for article published in Cancer Immunology, Immunotherapy, March 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent
5 patents

Citations

dimensions_citation
219 Dimensions

Readers on

mendeley
282 Mendeley
Title
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
Published in
Cancer Immunology, Immunotherapy, March 2010
DOI 10.1007/s00262-010-0833-1
Pubmed ID
Authors

Gerty Schreibelt, Jurjen Tel, Kwinten H. E. W. J. Sliepen, Daniel Benitez-Ribas, Carl G. Figdor, Gosse J. Adema, I. Jolanda M. de Vries

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 282 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 1%
Netherlands 1 <1%
Ireland 1 <1%
Australia 1 <1%
Austria 1 <1%
Denmark 1 <1%
Argentina 1 <1%
Unknown 272 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 76 27%
Researcher 66 23%
Student > Master 33 12%
Student > Bachelor 21 7%
Other 13 5%
Other 42 15%
Unknown 31 11%
Readers by discipline Count As %
Agricultural and Biological Sciences 97 34%
Immunology and Microbiology 49 17%
Medicine and Dentistry 45 16%
Biochemistry, Genetics and Molecular Biology 34 12%
Pharmacology, Toxicology and Pharmaceutical Science 5 2%
Other 19 7%
Unknown 33 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2022.
All research outputs
#3,331,852
of 23,114,117 outputs
Outputs from Cancer Immunology, Immunotherapy
#225
of 2,902 outputs
Outputs of similar age
#13,182
of 94,373 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#4
of 18 outputs
Altmetric has tracked 23,114,117 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,902 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,373 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.